Henry Waxman

BP Agrees to $20 Billion Gulf Coast Claims Fund Amid Deepwater Horizon Fallout

| Importance: 8/10

Under intense pressure from the Obama administration and Congress, BP agreed to establish a $20 billion independent claims fund to compensate victims of the Deepwater Horizon oil spill. The fund, administered by Kenneth Feinberg, represented an unprecedented corporate commitment to environmental …

BP (British Petroleum) Barack Obama Tony Hayward Kenneth Feinberg Gulf Coast Claims Facility +2 more compensation-fund corporate-accountability environmental-justice bp-deepwater-horizon obama-administration
Read more →

Erik Prince Testifies Before Congress Defending Blackwater Despite Evidence of 195 Shooting Incidents

| Importance: 8/10

Erik Prince testified before the House Committee on Oversight and Government Reform for nearly four hours, defending Blackwater’s operations in Iraq despite overwhelming evidence of excessive force and lack of accountability. The hearing came weeks after the September 16, 2007 Nisour Square …

Erik Prince Blackwater House Oversight Committee Henry Waxman private-military iraq-war accountability-crisis congressional-oversight corporate-impunity
Read more →

Kenneth Lay Meets with Dick Cheney Energy Task Force

| Importance: 9/10

On April 17, 2001, Enron CEO Kenneth Lay met with Vice President Dick Cheney and his National Energy Policy Development Group (Energy Task Force), presenting a three-page “wish list” of corporate energy policy recommendations. This meeting was one of at least six interactions between …

Kenneth Lay Dick Cheney Enron National Energy Policy Development Group George W. Bush +1 more enron cheney energy-task-force corporate-capture corruption +2 more
Read more →

Hatch-Waxman Act Grants Pharma Patent Extensions While Creating Loopholes to Block Generics

| Importance: 8/10

President Reagan signs the Drug Price Competition and Patent Term Restoration Act, known as Hatch-Waxman, which ostensibly balances pharmaceutical innovation incentives with generic competition but creates loopholes that brand-name manufacturers exploit to extend monopoly pricing for decades. The …

Orrin Hatch Henry Waxman Ronald Reagan Pharmaceutical Research and Manufacturers of America healthcare pharmaceutical-industry regulatory-capture patent-abuse lobbying
Read more →